US 2012/0083520 A1Published application

Ghrelin binding nucleic acids

AssigneeNOXXON Pharma AG

InventorsSteffen Helmling, Dirk Eulberg, Christian Maasch, Sven Klussmann

Life of this patent

Estimating the term…

Abstract

The present invention is related to a nucleic acid antagonist of ghrelin.

Claims29

Dependent claims

An antagonist of ghrelin, wherein the antagonist is a nucleic acid which specifically binds ghrelin.

Dependencies are inferred from the claim text.

Facts

Application: 12/776,377Filed 8 May 2010
Priority: EP 02017317.51 Aug 2002
Published: 5 Apr 2012
Term ends: Not estimatedThe source records don’t support an estimate.

Classification12 codes

C12N 15/115
DNA or RNA fragments; Modified forms thereof ; Non-coding nucleic acids having a biological activity: aptamers, i.e. nucleic acids binding a…
A61P 1/14
Drugs for disorders of the alimentary tract or the digestive system: prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics,…
A61P 3/00
Drugs for disorders of the metabolism
A61P 3/04
Drugs for disorders of the metabolism: anorexiants; Antiobesity agents

Family

Application10/522,582Continuation · filed 24 May 2006
Application12/776,377Continuation
US 2006/0257867 A1Published application
US 7,750,140 B2Related patent
US 2012/0083520 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results